The Sales & Marketing Effectiveness in Chemicals Forum will bring together industry leaders as well as experts responsible and deeply involved in sales and marketing strategies.
5 digital health innovations reshaping pharma industry
Big data, digital technology and internet are constantly transforming every sphere of our day-to-day lives. Cisco predicts that 50 billion devices (smartphones, household gadgets and office equipment) will be wirelessly connected via a network of sensors to the internet by 2020.
Starting with sectors like information technology, automotive industry, telecommunications, aerospace and defence, innovation has finally reached the pharmaceutical industry on a larger scale. Pharma companies filed 12% more patents in 2014 than the year before and four pharmaceutical companies made it to the list of the Top 20 World's Most Innovative Companies created by Forbes.
The growing intersection of biology and technology stands behind the increasing impact of digital health innovations on the pharma industry.
What are the main digital trends boosting the pharmaceutical industry in 2016?
1. Precision medicine
To understand the biological basis of a disease, precision medicine converts DNA into data through a process called genome sequencing. It helps researchers predict the types of patients a drug will be most effective for, and who is likely to experience severe adverse effects, subsequently enabling the development of more targeted therapies.
AstraZeneca UK is among the companies reportedly working with Genomics England on their project to sequence 100,000 genomes from 70,000 NHS patients with rare diseases and cancer. Pfizer has struck a deal with 23andMe which will give them access to their community of patients with Parkinson’s and Crohn’s disease in order to look for genetic clues to their causes.
2. mHealth sensors
Mobile and wearable devices that can track movement, take measurements and record information are highly useful in post-market studies. By allowing people to participate in studies more easily, an mHealth app can engage very large numbers of individuals in different locations. By increasing the amount of data, your pool becomes more representative, naturally resulting in more accurate results.
3. 3D printing
The experiments and their results so far show the potential of 3D printed drugs to change not only the way drugs are manufactured, but also administered. By making slight adjustments to the software before printing, hospitals could adjust doses for individual patients, a process of personalisation that is otherwise prohibitively expensive.
With their microscopic size, nanoparticles can easily travel around the human body in the blood stream and assist in the delivery of anti-cancer drugs. Medical researchers are also investigating the potential to use microscopic robots called nanobots, which can be preprogrammed to perform tasks inside the human body.
5. Artificial intelligence
Computers with learning capabilities (e.g. IBM Watson) are able to digest and interpret millions of pages of scientific literature and data. These computers can assist pharma companies in the development of new drugs and improving existing ones.
Johnson & Johnson collaborates is teaching Watson to read and understand scientific papers that detail clinical trial outcomes used to develop and evaluate medications and other treatments. Sanofi is exploring how it can speed up the discovery of alternative indications for their existing drugs.
Steve Jobs predicted the intersection of biology and technology to be the biggest innovation of the 21st century and you can be a part of it. Meet the experts presenting at Fleming.'s 4th Annual Open Innovation - Life Science, Pharma & Biotech, learn from innovative companies, gain insights from other industries, and find an ally to collaborate. Joining knowledge and budgets seems to be the most effective way to exploit the costly innovation to its fullest. The next digital trend influencing the pharma industry and the lives of many patients can be the one which arose from this cooperation.
Interested in this topic?
Advanced Protein Aggregation & Characterization
This training will focus on occurrence of particles in drug products, effects of protein aggregates, critical process and parameters. Attendees will gain overview of on utility and limits of predictive experiments, learn concerns from the authorities and relevant aggregation guidelines, and more.
CMC Analytical Comparability: Methods & Strategies for Biologics, Biosimilars & Biobetters
Attendees will be introduced to comparability in biosimilar development, the analytical strategies of protein characterization of biosimilars, the structure of proteins, in vitro pharmacology and much more.
Corporate Compliance & Transparency in the Pharmaceutical Industry
This two-day conference will serve as a platform for an open and dynamic dialogue with HCPs and patients to achieve common goals. Learn how to embed compliance in the business and develop one simple system for managing compliance & transparency in a complex and regulated environment.
Turning Patient Feedback to Meaningful Resource for Care Delivery
Read the interview with Nasser Al Naimi, Deputy Chief Quality Officer at Hamad Medical Corporation, and Co-Director at Hamad Healthcare Quality Institute, and learn how to turn your data into strategic information to drive patient-family centered care.
Creating & Leading Patient Experience Excellence
Read the full interview with Dr. Ahmed Mohammad Abu-Abah, CEO at King Abdullah BinAbdulaziz University Hospital and gain insight into the creating & leading patient experience excellence.
Excelling in PV is not only about Technical Expertise
For a PV leader, to be successful can look like a daily Herculean work: meeting a crucial mandate to minimize harm to patients, while ensuring that a product is prescribed to the right population, and maintaining the highest level of compliance within a very complex set of worldwide regulations.